Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT00075881 · COMPLETED

Trial details

NCT number: NCT00075881
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2004-01-01
Primary completion: 2012-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.